Proud to call New Jersey home
Johnson & Johnson was the first innovative healthcare company to be founded in New Jersey. 140 years later we remain an innovation powerhouse, advancing healthcare in the Garden State—and around the globe.
Through scientific innovation and technology, Johnson & Johnson is tackling the world’s toughest health challenges. Last year, we spent $15 billion on research & development, with significant investment in New Jersey.
Our state-of-the-art manufacturing and research facilities are developing next-generation treatments, including multiple myeloma cancer therapies and cutting-edge antibacterial surgical sutures, right here in the state of New Jersey.
We take pride in calling New Jersey home—a state renowned for its vibrant communities, top ranking education system and STEM and healthcare leadership.
Our state-of-the-art manufacturing and research facilities are developing next-generation treatments, including multiple myeloma cancer therapies and cutting-edge antibacterial surgical sutures, right here in the state of New Jersey.
We take pride in calling New Jersey home—a state renowned for its vibrant communities, top ranking education system and STEM and healthcare leadership.
Johnson & Johnson has a 140-year history in our home state of New Jersey. We are proud to have helped make our state a global innovation powerhouse.
Joaquin Duato
Chairman and CEO
What’s new in NJ
Johnson & Johnson to collaborate with the New York Jets to promote better health in the community
Teaming up to support healthcare in the local community and empower residents.
Johnson & Johnson inspires the next generation of STEM leaders with the second annual WiSTEM²D camp in New Brunswick
Across three days, a group of New Jersey high school students participated in a broad range of STEM-focused activities, workshops, speaker sessions and a site tour as part of Johnson & Johnson’s WiSTEM²D Camp global initiative.
Johnson & Johnson brings New Jersey students to Washington, D.C. to build civic leadership
Eleven high school students from New Jersey—each representing a different congressional district—traveled to Washington, D.C., earlier this year to participate in the Close Up Foundation’s Washington, D.C. civic engagement program as Johnson & Johnson Scholars.
Johnson & Johnson helps prepare the workforce of the future with the launch of NJBioFutures
As the Founding Sponsor, J&J contributes $1 million to accelerate the creation of industry-aligned curricula and state-of-the-art training facilities at three leading New Jersey community colleges
Johnson & Johnson Supports and Celebrates the Middlesex College/Hackensack Meridian Health Nursing Program’s Class of 2024
J&J provides annual scholarships to the program to elevate, empower, and advocate for the nursing profession.
Johnson & Johnson establishes new Rutgers-Newark scholarship in honor of the late Lt. Gov. Sheila Y. Oliver
The charitable gift honors the legacy of New Jersey’s first Black woman lieutenant governor and supports the next generation of NJ public service leaders
Johnson & Johnson honored as Special Olympics New Jersey’s 2023 Volunteer Group of the Year
For Developmental Disabilities Awareness Month, learn how our longstanding partnership with Special Olympics New Jersey continues to change lives 20 years after it began
J&J by the numbers
$15 billion
Invested in research & development across Innovative Medicine and MedTech globally
33
The number of J&J clinical trials currently underway in New Jersey
#1
Ranked #1 in the Pharmaceutical Category on the Fortune World’s Most Admired Companies list for the 10th year in a row in February 2023
At work in New Jersey
-
Meet a nurse who leads clinical trials to find innovative cancer therapies
Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing. -
“I’ve developed innovative sutures that help save lives”
Johnson & Johnson got its start as a pioneer of sterile surgical sutures and continues to make advancements today. Jesse Nawrocki, Ph.D., shares how he and his award-winning team are working to make surgery easier for doctors and safer for patients. -
Learn about 3 health advocates who gather in NJ every year for empowerment and connection
In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
History spotlight
Illustration of the first Johnson & Johnson building in New Brunswick, New Jersey in 1886.
To learn more about J&J’s heritage in New Jersey, please visit Our History page.
Image courtesy: Johnson & Johnson Archives
The roots of Johnson & Johnson’s modern Innovative Medicines business begin in 1940 with the establishment of a pharmaceutical manufacturing facility in Linden, New Jersey.
Johnson & Johnson put the first mass produced sterile surgical dressings and sutures on the market in 1886 and 1887 to help make surgery survivable for patients.
Image courtesy: © Andrew McCaul Photography
Ethicon sutures manufactured in Somerville, New Jersey were used in the first successful human to human heart transplant in Cape Town, South Africa in 1967.
Image courtesy: © Andrew McCaul Photography
